A study published on Oct 3rd, 2022

concluded Ketamine is being utilized

to treat psychiatric outpatients with

multiple mental illnesses not limited to depression.

Average depression and anxiety levels

significantly improve throughout

ketamine treatment and do not regress 

to baseline during patients’ maintenance treatment phase.